Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responses

Affiliations

• ¹ Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 171 65, Sweden. Electronic address: daniel.sheward@ki.se.
• ² Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 171 65, Sweden.
• ³ Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
• ⁴ Department of Infectious Disease, Imperial College London, London, UK; The Pirbright Institute, Woking, UK.
• ⁵ Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 171 65, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.